Exclusive breastfeeding (EBF) has numerous maternal health benefits. However, EBF rates are lower in mothers with obesity. We sought to better understand whether maternal body composition measurements in early pregnancy are also predictive of lower rates of EBF. Healthy pregnant women with prepregnancy body mass index (BMI) of 17.5-51 kg/m 2 underwent determination of percent body fat (% body fat)
| INTRODUCTION
Breastfeeding is associated with many maternal health benefits in addition to improved infant health outcomes including lower risk of infection, obesity, diabetes, and sudden infant death syndrome ("Breastfeeding and the use of human milk," 2012). Women who breastfeed have decreased risk for metabolic syndrome (Choi, Kim, Cho, Kim, & Shim, 2017; Gunderson et al., 2010; Ram et al., 2008) , Type 2 diabetes mellitus (T2DM; Ip et al., 2007; Schwarz et al., 2010; Stuebe, Rich-Edwards, Willett, Manson, & Michels, 2005) , cardiovascular disease (CVD; Peters et al., 2017; Schwarz et al., 2009; , and cancer (Chowdhury et al., 2015; Ip et al., 2007) and decreased all-cause mortality (Bartick et al., 2017) in later life compared with women who do not breastfeed. Several studies have reported that the degree of maternal health benefit is proportional to lactation intensity and duration, suggestive of a dose-response relationship (Gunderson et al., 2015; Peters et al., 2017; Ziegler et al., 2012) . The greatest long-term maternal health benefits have been shown in women who follow the World Health Organization recommendation for exclusive breastfeeding (EBF) for the first 6 months of life without formula supplementation or introduction of other foods or beverages (Organization, 2002) .
However, women who are obese are significantly less likely to exclusively breastfeed (Amir & Donath, 2007; Donath & Amir, 2008; Hauff, Leonard, & Rasmussen, 2014) . This is reflected in lower intention to breastfeed (Thompson et al., 2013; Wojcicki, 2011) , earlier formula supplementation (Donath & Amir, 2008; Hauff et al., 2014; Martinez, Chapman, & Perez-Escamilla, 2016) , and increased risk of disrupted lactation (Stuebe et al., 2014; Vanky et al., 2012) , defined as early, undesired weaning attributed to lactation dysfunction. Despite correction for psychosocial factors (Hauff et al., 2014) , obesity remains a significant risk factor for non-EBF, suggesting a biological basis for lactation dysfunction.
EBF requires proper development and normal function of breast glands in order to meet the average newborn's need to feed 8-12 times and consume an average of 710 mL of breastmilk daily (Dewey, 1997) . Obesity is implicated as a cause of delayed lactogenesis and low-milk supply (Nommsen-Rivers, Chantry, Peerson, Cohen, & Dewey, 2010; Nommsen-Rivers, Dolan, & Huang, 2012; Preusting, Brumley, Odibo, Spatz, & Louis, 2017) , which both contribute to lactation dysfunction due to insufficient milk production requiring early formula supplementation (O'Sullivan, Perrine, & Rasmussen, 2015) . Animal studies support this association of increased fat mass and low-milk supply (Morrow, 1976; Revell, Williams, Mullan, Ranford, & Smits, 1998a , 1998b . The "preset" hypothesis suggests that maternal metabolic factors present before delivery determine lactation initiation and duration as well as later life metabolic risk ). If true, a candidate link between maternal obesity and decreased EBF rates could be in variations of percent body fat in early gestation.
In order to explore associations among maternal obesity, EBF, and long-term maternal health, it is important to distinguish between intended EBF versus planned formula use and undesired introduction of formula due to lactation dysfunction. A significant limitation of longitudinal studies supporting the correlation between breastfeeding and improved maternal health is the lack of information regarding maternal EBF intent, which is critical because breastfeeding intention and planned duration are among the strongest factors associated with length of lactation (Scott & Binns, 1999) . By studying women who intended EBF and initiated breastfeeding, we can focus on factors other than intention, including physiological factors, which may influence the relationship between increased maternal obesity and decreased rates of EBF.
We therefore sought to address the research gap related to the impact of maternal obesity and body composition in early pregnancy on EBF by focusing on women intending EBF to exclude planned formula use. We also explored if maternal body composition influenced when infant formula supplementation was introduced. Our primary hypothesis was that maternal obesity is a risk factor for decreased rates of EBF and earlier introduction of formula supplementation among women intending EBF. In addition, we hypothesized that maternal obesity is a risk factor for earlier cessation of lactation. The calculations from von Raaij (van Raaij, Peek, Vermaat-Miedema, Schonk, & Hautvast, 1988) were used to correct for changes in fat free mass density based on gestational age, as previously described (Marshall et al., 2016) . Percent body fat was determined by dividing maternal fat mass (kg) as calculated above by total maternal weight (kg) × 100. Subjects were then separated into % body fat quartiles in early and late gestation.
Our primary outcome was the rate of EBF at 6 weeks and 6 months by maternal BMI category and % body fat quartile in early and late gestation. Subjects completed modified Infant Feeding
Practice Study II surveys (Fein et al., 2008) online at 6 weeks and 6 months postpartum. These time points were chosen as 6 weeks postpartum is the traditional timing for the routine postpartum exam, and the majority of employed women have not yet returned to
Key messages
• Elevated prepregnancy BMI and body fat percent in early gestation are associated with significantly lower rates of exclusive breastfeeding at 6 weeks postpartum among women intending exclusive breastfeeding.
• Introduction of formula within the first 2 weeks postpartum accounts for 74% of formula introduction within the first 6 weeks among women intending exclusive breastfeeding.
• Maternal obesity is associated with lower rates of EBF and higher rates of lactation cessation at 6 months postpartum.
work, and 6 months is the recommended duration for EBF prior to initiating solid food supplementation. Breastfeeding intention (breast, formula, and both) and intended months of breastfeeding duration were assessed. The end of EBF was determined by selfreport of infant age in weeks at first use of formula supplementation.
Exclusive breastfeeding was confirmed on the 6-week and 6-month postpartum surveys. As the primary intent of this study was to evaluate introduction of formula supplementation, women whose infants started complementary solid foods between 4 and 6 months but did not receive formula supplementation were considered to be EBF (n = 45). Duration of lactation was determined by maternal survey response at 6 weeks and 6 months postpartum. Women were considered to have stopped lactating when they were no longer providing breastmilk to their infant through either breastfeeding or pumping.
Given the physiologic and psychosocial differences between primiparous and multiparous mothers, we also examined the relationship between body composition and EBF stratified by parity.
| Statistical analysis
We used descriptive statistics to characterize the demographic profile of our cross-sectional sample. We analysed unadjusted associations between BMI and the end of EBF via Kaplan Meier survival analysis by graphing the prevalence of formula introduction over time with women of each BMI category using a unique line. We employed multivariable logistic regression modelling to assess the association between maternal BMI and % body fat in late gestation and EBF among women intending EBF. We controlled for potential confounding variables between the BMI categories, including maternal age, gestational weight gain, smoking status, and intended duration of breastfeeding less than 6 months. Due to universal rates of EBF in the lowest quartiles for % body fat in early gestation, we were unable to perform adjusted analysis. To evaluate the impact of parity on EBF, we analysed unadjusted rates of EBF at 6 weeks and 6 months postpartum stratified by maternal BMI and % body fat quartile and separated by maternal parity.
| RESULTS
Women with prepregnancy BMI ≥30 kg/m 2 were less likely to intend EBF compared with women of normal weight and overweight (78.8%
vs. 95.5 and 96.2%, respectively, P = 0.006, Table SS1 ). Women with BMI ≥25 kg/m 2 were less likely to intend to breastfeed for at least 12 months compared with women of lower BMI (P = 0.002). All subjects intended to breastfeed and initiated breastfeeding. By 6 weeks postpartum, three women had stopped lactating, and there was no association of cessation of lactation likelihood with maternal body composition. No subjects intending EBF had stopped lactating by 6 weeks. However, by 6 months postpartum, increasing maternal prepregnancy BMI was significantly associated with earlier lactation cessation ( Figure SS1 and Table S2 ). No women with normal BMI or % body fat in the first quartile in early or late gestation had stopped lactating at 6 months postpartum versus over 20% for women with BMI ≥25 kg/m 2 (P = 0.001) or % body fat in the third and fourth quartiles in early or late gestation (P = 0.02 and 0.01, respectively).
FIGURE 1 Subject flow chart
The remainder of the results refer to the final analytic sample of 140 subjects who intended EBF, which included 71 early enrollers and 69 late enrollers. Women who were obese were more likely to be younger, current smokers, and have lower gestational weight gain (Table 1) . There were no differences in parity, mode of delivery, birthweight, gestational age at delivery, or returning to work. Women with normal BMI were significantly more likely to be EBF during the first 6 months postpartum compared with women who were overweight or obese (Figure 2 ). EBF duration was not different between women who were overweight compared with those who were obese.
Seventy-four percent of women who started formula supplementation within the first 6 weeks after delivery despite EBF intent did so within the first 2 weeks. Of the 27 women who initiated formula in the first 6 weeks, seven started prior to hospital discharge, five started within the first week, and eight started within 2 weeks after delivery.
After adjustment for confounders, the odds ratio for EBF at 6 weeks postpartum for women who were overweight/obese was 0.24 (95% confidence interval, CI [0.08-0.75], P = 0.01; TTable 2).
Women in the fourth quartile for % body fat in late pregnancy were significantly less likely to be EBF compared with women in the first quartile. By 6 months postpartum, women who were overweight or obese and who had a % body fat greater than the first or second quartile in late gestation were all significantly less likely to be EBF.
After separation by parity, primiparous women with a BMI ≥25 kg/m 2 had significantly decreased rates of EBF at 6 weeks postpartum compared with normal weight women (P = 0.01; Table 3 ). All of the primiparous women with % body fat in the first or second quartile in early pregnancy were EBF at 6 weeks postpartum compared with 66.7% of women in the third quartile and 63.6% of women in the fourth quartile (P = 0.03). These differences were not apparent when separated by % body fat quartile in late gestation. Multiparous women who were overweight or obese prior to pregnancy were significantly less likely to be EBF at 6 weeks postpartum (P = 0.02) compared with women of normal weight, but there were no differences by % body fat quartile in early or late gestation. At 6 months postpartum, maternal BMI ≥25 kg/m 2 remained significantly associated with decreased rates of EBF, with 76.3% of primiparous women with normal BMI reporting EBF, compared with 19.4% of primiparous women who were overweight or obese (P = 0.001) and none of the women in the fourth quartile for % body fat in early or late gestation. In contrast to 6 weeks postpartum, there were significant variations in EBF rates among multiparous women by % body fat in late gestation as well as by prepregnancy BMI, with no difference by % body fat in early gestation.
| DISCUSSION
Among women intending to exclusively breastfeed, maternal obesity was significantly associated with lower rates of EBF at 6 weeks and 6 months postpartum, despite correction for maternal age, gestational weight gain, smoking status, and intended duration of breastfeeding.
Importantly, we found that primiparous women with elevated prepregnancy BMI and % body fat in early pregnancy were at the greatest risk for early introduction of formula. Although these women all intended EBF, maternal obesity was significantly associated with lower EBF rates, as evidenced by greater formula introduction rates primarily within the first 2 weeks postpartum. This suggests that physiologic differences associated with increased fat mass, which manifest as lactation dysfunction early in the postpartum period, may be driving the differences in EBF rates by maternal obesity more than psychosocial factors.
Although BMI is commonly used as a surrogate for % body fat, we have shown it to poorly correlate with actual % body fat on an FIGURE 2 Kaplan-Meier survival analysis for end of exclusive breastfeeding by infant age in weeks over the first 6 months of life due to introduction of formula, among women intending exclusive breastfeeding stratified by prepregnancy body mass index individual level (Marshall et al., 2016) . Thus, % body fat is important to distinguish from BMI when attempting to determine the impact of maternal body composition on capacity for EBF. Among primiparous women intending EBF, 86.8% in the normal BMI category were EBF at 6 weeks postpartum, whereas 100% of women in the first and second quartile for % body fat in early gestation were EBF. By late pregnancy, maternal % body fat was no longer significantly associated with lower rates of EBF. The physiological links that explain an association between maternal % body fat in early gestation and EBF are yet to be determined. Our data suggest that % body fat may have a threshold effect rather than a dose-response effect or may be one component of multiple physiologic factors responsible for breast milk production. One possibility would be an impairment of normal breast glandular development in early pregnancy. Although breast glandular maturation begins in puberty, terminal differentiation is not complete until after full term pregnancy and lactation (Martinson, Lyons, Giles, Borges, & Schedin, 2013) . In animal studies, abnormalities in fat mass are associated with abnormal mammary gland development and low-milk supply. In pigs, increased fat mass associates with up to 15% lower milk production compared with normal weight sows, which the authors speculated may be due to poor mammary development during pregnancy (Revell et al., 1998a (Revell et al., , 1998b . Obese mice, as a result of a high-fat diet, have been shown to have abnormal ductal branching and reduced alveolar development that associates with impaired lactogenesis (Flint, Travers, Barber, Binart, & Kelly, 2005) . In addition, rat pups born to obese dams on a high-fat diet were more likely to die in the first 3 days of life compared with pups born to dams on a control diet, which was postulated to be related to delayed lactogenesis and insufficient milk supply (Shaw, Rasmussen, & Myers, 1997) . These animal models provide a plausible biological link between increased maternal % body fat, reduced mammary gland development, and decreased milk production, which could result in lower EBF rates as shown in our study population. It is also possible that these differences are driven by different postnatal practices or social confounders, which need to be assessed in greater detail.
Elevated maternal prepregnancy BMI was associated with significantly higher rates of stopping breastfeeding by 6 months postpartum, with over 20% of women who were overweight/obese having ceased to provide breastmilk compared with no women of normal BMI. Because several studies have suggested that length of lactation plays an important role in long-term maternal health benefits (Gunderson et al., 2010; Ram et al., 2008; Schwarz et al., 2009; Stuebe et al., 2005; , it is important to more closely examine why women with higher prepregnancy BMI are stopping breastfeeding earlier compared with their normal weight peers.
Although the primary intent of this study was to explore the relationship between maternal obesity and EBF among women intending EBF, it was notable that women with elevated BMI were much more likely to report intended mixed breast and formula feeding.
Future studies are needed to explore the factors that influence the intention to combine breast and formula feeding rather than EBF as recommended.
Limitations to this study include a limited number of subjects, which was compounded by the loss of subjects due to incomplete survey completion. Although this may have resulted in an overestimation of differences in EBF rates, it is potentially more likely that findings should have been biased towards the null. Additionally, EBF intention was assessed at 6 weeks postpartum, which may not have accurately reflected predelivery intention. Strengths of this study include the detailed information on maternal EBF intent, % body fat, and breastfeeding behaviours for the first 6 months among a population of women with high-EBF intention, which allows for characterization of the relationship between maternal % body fat and EBF without confounding related to intention differences. The majority of largedatabase studies examining the impact of breastfeeding on maternal health outcomes to date have been hampered by limited data regarding the intensity of breastfeeding, as most relied on maternal recollection several years later as to whether they breastfed (yes or no) and how long they breastfed, which has been shown to both over and underestimate breastfeeding duration (Burnham et al., 2014) . As such, TABLE 3 Association of maternal body composition and parity on exclusive breastfeeding rates at 6 weeks and 6 months postpartum among women intending exclusive breastfeeding (primiparous n = 80, multiparous n = 60), n (%) the ability to establish EBF is substantially limited. A critical limitation of these studies, in contrast to our work, is the lack of distinction between desired formula use and undesired formula introduction due to lactation dysfunction, which is essential to determine the role of breastfeeding in maternal long-term health.
In summary, this study found that among women intending EBF, elevated prepregnancy BMI and higher % body fat in early pregnancy were significantly associated with lower rates of EBF and higher rates of lactation cessation as of 6 months postpartum. It is possible that the difference in rates of EBF by maternal BMI are driven by confounding factors, and it is important for future studies to fully explore this possibility. Although some studies that have attempted to increase EBF rates among women who are obese have shown improvement in breastfeeding initiation, rates of EBF remain unchanged (Chapman et al., 2013; Martin, MacDonald-Wicks, Hure, Smith, & Collins, 2015) . Our findings suggest that a primary focus on psychosocial factors in these studies would miss important physiologic barriers related to increased fat mass in early gestation that contributed to low-EBF rates. It would also miss the opportunity to speculate that intervention prior to pregnancy or in early pregnancy may be an important tool to increase rates of EBF. A similar implication of our data is that unrecognized physiologic barriers present prepregnancy and early in gestation, rather than failure to EBF, may also be responsible for increased long-term maternal risk for diabetes, obesity, T2DM, and CVD and that future studies on breastfeeding and long-term maternal health need to address lactation intention and dysfunction, not just duration. By better understanding the early physiological contributors to breastfeeding success, we can develop more effective interventions.
